Currently, attenuation of TNBC progression by modulating the cancer signaling pathways such as by inhibiting CDK14, induction of chemokines such as CXCL14, and inhibition of NF-κB is promising [12,13,14]. The gene discussed is NFKB1; the disease is cancer.